ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

This study is currently recruiting patients.

Sponsored by: European Organization for Research and Treatment of Cancer
Information provided by: National Cancer Institute (NCI)

Purpose

RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment.

PURPOSE: Clinical trial to study young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.

Condition Treatment or Intervention
sexual dysfunction and infertility
sexuality and reproductive issues
psychosocial effects/treatment
stage I breast cancer
stage II breast cancer
 Procedure: psychosocial assessment/care
 Procedure: supportive care/therapy

MedlinePlus related topics:  Breast Cancer
Genetics Home Reference related topics:  breast cancer

Study Type: Interventional
Study Design: Treatment

Official Title: Study of Attitudes Toward the Risk of Infertility Related to Adjuvant Therapy in Women With Early Breast Cancer

Further Study Details: 

OBJECTIVES:

OUTLINE: This is a multicenter study.

Patients complete a questionnaire administered by a nontreating physician.

PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.

Eligibility

Ages Eligible for Study:  up to  35 Years,  Genders Eligible for Study:  Both

Criteria

DISEASE CHARACTERISTICS:

PATIENT CHARACTERISTICS: Age

Sex

Menopausal status

Performance status

Life expectancy

Hematopoietic

Hepatic

Renal

Other

PRIOR CONCURRENT THERAPY: Biologic therapy

Chemotherapy

Endocrine therapy

Radiotherapy

Surgery


Location and Contact Information


Belgium
      Centre Hospitalier Etterbeek Ixelles, Brussels,  B-1050,  Belgium; Recruiting
Contact Person  32-641-4111 

      Institut Jules Bordet, Brussels,  1000,  Belgium; Recruiting
Contact Person  32-2-541-3181 

Turkey
      Marmara University Hospital, Istanbul,  81190,  Turkey; Recruiting
Contact Person  90-327-5050 

Yugoslavia
      Institute of Oncology and Radiology of Serbia, BELGRADE,  11000,  Yugoslavia; Recruiting
Contact Person  381-361-4660 

Study chairs or principal investigators

Angelo Di Leo, MD,  Misericordia e Dolce Hospital   

More Information

Clinical trial summary from the National Cancer Institute's PDQ® database

Study ID Numbers:  CDR0000304757; EORTC-10002; BIG-3-98
Record last reviewed:  May 2003
Record first received:  June 5, 2003
ClinicalTrials.gov Identifier:  NCT00062400
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2004-11-05
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act